Protagenic Therapeutics, Inc. (PTIX) NASDAQ
0.50
+0.0993(+24.78%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.50
+0.0993(+24.78%)
Currency In USD
| Previous Close | 0.4 |
| Open | 0.5 |
| Day High | 0.55 |
| Day Low | 0.5 |
| 52-Week High | 6.2 |
| 52-Week Low | 0.25 |
| Volume | 3,818 |
| Average Volume | 5,792 |
| Market Cap | 905,104 |
| PE | -0.04 |
| EPS | -13.13 |
| Moving Average 50 Days | 0.64 |
| Moving Average 200 Days | 1.6 |
| Change | 0.1 |
Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates
GlobeNewswire Inc.
Jul 30, 2025 12:30 PM GMT
NEW YORK and SANTA BARBARA, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) (the “Company”) today announces that on July 18, 2025, the Japanese Patent Office granted Patent JP 7714571B, a patent which runs until